# 3D Systems Corp: financial statements, quarterly

DDD · NYSE · CIK 910638 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ddd.md) · [Financials](/companies/ddd/financials.md) · [Filings](/companies/ddd/filings.md) · [Insiders](/companies/ddd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ddd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [124](/filings/0000910638-24-000046.md) | [115 d](/filings/0001628280-26-015997.md) | [103](/filings/0000910638-25-000010.md) | [113](/filings/0000910638-25-000016.md) | [113](/filings/0001628280-25-048915.md) | [111 d](/filings/0001628280-26-015997.md) | [94.5](/filings/0001628280-26-033633.md) | [94.8](/filings/0001628280-26-051898.md) | [91.2](/filings/0001628280-25-048915.md) | [106 d](/filings/0001628280-26-015997.md) | [95.5](/filings/0001628280-26-033633.md) | [94.6](/filings/0001628280-26-051898.md) |
| Cost of revenue | $m | [68.4](/filings/0000910638-24-000046.md) | [70.9 d](/filings/0001628280-26-015997.md) | [62.0](/filings/0000910638-25-000010.md) | [66.2](/filings/0000910638-25-000016.md) | [71.2](/filings/0001628280-25-048915.md) | [76.6 d](/filings/0001628280-26-015997.md) | [61.9](/filings/0001628280-26-033633.md) | [58.7](/filings/0001628280-26-051898.md) | [61.8](/filings/0001628280-25-048915.md) | [73.5 d](/filings/0001628280-26-015997.md) | [61.2](/filings/0001628280-26-033633.md) | [60.1](/filings/0001628280-26-051898.md) |
| Gross profit | $m | [55.4](/filings/0000910638-24-000046.md) | [44.0 d](/filings/0001628280-26-015997.md) | [40.9](/filings/0000910638-25-000010.md) | [47.1](/filings/0000910638-25-000016.md) | [41.7](/filings/0001628280-25-048915.md) | [34.4 d](/filings/0001628280-26-015997.md) | [32.7](/filings/0001628280-26-033633.md) | [36.2](/filings/0001628280-26-051898.md) | [29.4](/filings/0001628280-25-048915.md) | [32.8 d](/filings/0001628280-26-015997.md) | [34.3](/filings/0001628280-26-033633.md) | [34.5](/filings/0001628280-26-051898.md) |
| Research and development | $m | [22.0](/filings/0000910638-24-000046.md) | [22.5 d](/filings/0001628280-26-015997.md) | [23.5](/filings/0000910638-25-000010.md) | [22.0](/filings/0000910638-25-000016.md) | [20.8](/filings/0001628280-25-048915.md) | [20.2 d](/filings/0001628280-26-015997.md) | [19.7](/filings/0001628280-26-033633.md) | [17.4](/filings/0001628280-26-051898.md) | [16.0](/filings/0001628280-25-048915.md) | [12.0 d](/filings/0001628280-26-015997.md) | [9.6](/filings/0001628280-26-033633.md) | [10.0](/filings/0001628280-26-051898.md) |
| Selling, general and administrative | $m | [33.4](/filings/0000910638-24-000046.md) | [59.5 d](/filings/0001628280-26-015997.md) | [57.3](/filings/0000910638-25-000010.md) | [51.5](/filings/0000910638-25-000016.md) | [58.0](/filings/0001628280-25-048915.md) | [43.4 d](/filings/0001628280-26-015997.md) | [49.8](/filings/0001628280-26-033633.md) | [34.1](/filings/0001628280-26-051898.md) | [34.7](/filings/0001628280-25-048915.md) | [42.7 d](/filings/0001628280-26-015997.md) | [31.3](/filings/0001628280-26-033633.md) | [35.1](/filings/0001628280-26-051898.md) |
| Operating income | $m | [(13.6)](/filings/0000910638-24-000046.md) | [(327) d](/filings/0001628280-26-015997.md) | [(39.9)](/filings/0000910638-25-000010.md) | [(26.4)](/filings/0000910638-25-000016.md) | [(181)](/filings/0001628280-25-048915.md) | [(30.4) d](/filings/0001628280-26-015997.md) | [(36.8)](/filings/0001628280-26-033633.md) | [(15.4)](/filings/0001628280-26-051898.md) | [(21.3)](/filings/0001628280-25-048915.md) | [(22.7) d](/filings/0001628280-26-015997.md) | [(6.6)](/filings/0001628280-26-033633.md) | [(10.6)](/filings/0001628280-26-051898.md) |
| Income tax | $m | [0.2](/filings/0000910638-24-000046.md) | [(1.0) d](/filings/0001628280-26-015997.md) | [1.4](/filings/0000910638-25-000010.md) | [0.5](/filings/0000910638-25-000016.md) | [(4.3)](/filings/0001628280-25-048915.md) | [4.7 d](/filings/0001628280-26-015997.md) | [0.7](/filings/0001628280-26-033633.md) | [11.0](/filings/0001628280-26-051898.md) | [(2.6)](/filings/0001628280-25-048915.md) | [5.8 d](/filings/0001628280-26-015997.md) | [1.5](/filings/0001628280-26-033633.md) | [0.4](/filings/0001628280-26-051898.md) |
| Net income | $m | [(11.7)](/filings/0000910638-24-000046.md) | [(293) d](/filings/0001628280-26-015997.md) | [(16.0)](/filings/0001628280-25-048915.md) | [(27.3)](/filings/0001628280-25-048915.md) | [(179)](/filings/0001628280-25-048915.md) | [(33.7) d](/filings/0001628280-26-015997.md) | [(37.0)](/filings/0001628280-26-051898.md) | [104](/filings/0001628280-26-051898.md) | [(18.1)](/filings/0001628280-25-048915.md) | [(19.5) d](/filings/0001628280-26-015997.md) | [(4.4)](/filings/0001628280-26-051898.md) | [(12.9)](/filings/0001628280-26-051898.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0000910638-24-000046.md) | not reported | [(0.12)](/filings/0000910638-25-000010.md) | [(0.21)](/filings/0000910638-25-000016.md) | [(1.35)](/filings/0001628280-25-048915.md) | not reported | [(0.28)](/filings/0001628280-26-033633.md) | [0.57](/filings/0001628280-26-051898.md) | [(0.14)](/filings/0001628280-25-048915.md) | not reported | [(0.03)](/filings/0001628280-26-033633.md) | [(0.09)](/filings/0001628280-26-051898.md) |
| Basic EPS | $ per share | [(0.09)](/filings/0000910638-24-000046.md) | not reported | [(0.12)](/filings/0000910638-25-000010.md) | [(0.21)](/filings/0000910638-25-000016.md) | [(1.35)](/filings/0001628280-25-048915.md) | not reported | [(0.28)](/filings/0001628280-26-033633.md) | [0.79](/filings/0001628280-26-051898.md) | [(0.14)](/filings/0001628280-25-048915.md) | not reported | [(0.03)](/filings/0001628280-26-033633.md) | [(0.09)](/filings/0001628280-26-051898.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [446](/filings/0000910638-24-000046.md) | [332](/filings/0001628280-26-015997.md) | [212](/filings/0000910638-25-000010.md) | [193](/filings/0000910638-25-000016.md) | [190](/filings/0001628280-25-048915.md) | [171](/filings/0001628280-26-015997.md) | [135](/filings/0001628280-26-033633.md) | [116](/filings/0001628280-26-051898.md) | [95.5](/filings/0001628280-25-048915.md) | [95.6](/filings/0001628280-26-051898.md) | [85.1](/filings/0001628280-26-033633.md) | [128](/filings/0001628280-26-051898.md) |
| Current assets | $m | [740](/filings/0000910638-23-000025.md) | [628](/filings/0000910638-25-000005.md) | [506](/filings/0000910638-24-000035.md) | [474](/filings/0000910638-24-000041.md) | [460](/filings/0000910638-24-000046.md) | [429](/filings/0001628280-26-015997.md) | [402](/filings/0000910638-25-000010.md) | [390](/filings/0000910638-25-000016.md) | [361](/filings/0001628280-25-048915.md) | [347](/filings/0001628280-26-051898.md) | [341](/filings/0001628280-26-033633.md) | [366](/filings/0001628280-26-051898.md) |
| Total assets | $m | [1,393](/filings/0000910638-23-000025.md) | [991](/filings/0000910638-25-000005.md) | [857](/filings/0000910638-24-000035.md) | [821](/filings/0000910638-24-000041.md) | [658](/filings/0000910638-24-000046.md) | [609](/filings/0001628280-26-015997.md) | [583](/filings/0000910638-25-000010.md) | [588](/filings/0000910638-25-000016.md) | [555](/filings/0001628280-25-048915.md) | [522](/filings/0001628280-26-051898.md) | [513](/filings/0001628280-26-033633.md) | [535](/filings/0001628280-26-051898.md) |
| Current liabilities | $m | [138](/filings/0000910638-23-000025.md) | [147](/filings/0000910638-25-000005.md) | [146](/filings/0000910638-24-000035.md) | [137](/filings/0000910638-24-000041.md) | [139](/filings/0000910638-24-000046.md) | [139](/filings/0001628280-26-015997.md) | [144](/filings/0000910638-25-000010.md) | [141](/filings/0000910638-25-000016.md) | [132](/filings/0001628280-25-048915.md) | [121](/filings/0001628280-26-051898.md) | [123](/filings/0001628280-26-033633.md) | [108](/filings/0001628280-26-051898.md) |
| Total liabilities | $m | [691](/filings/0000910638-23-000025.md) | [562](/filings/0000910638-25-000005.md) | [447](/filings/0000910638-24-000035.md) | [438](/filings/0000910638-24-000041.md) | [438](/filings/0000910638-24-000046.md) | [431](/filings/0001628280-26-015997.md) | [436](/filings/0000910638-25-000010.md) | [344](/filings/0000910638-25-000016.md) | [331](/filings/0001628280-25-048915.md) | [279](/filings/0001628280-26-051898.md) | [279](/filings/0001628280-26-033633.md) | [262](/filings/0001628280-26-051898.md) |
| Long-term debt | $m | [452](/filings/0000910638-23-000025.md) | [319](/filings/0000910638-25-000005.md) | [211](/filings/0000910638-24-000035.md) | [211](/filings/0000910638-24-000041.md) | [212](/filings/0000910638-24-000046.md) | [212](/filings/0001628280-26-015997.md) | [212](/filings/0000910638-25-000010.md) | [123](/filings/0000910638-25-000016.md) | [123](/filings/0001628280-25-048915.md) | [86.4](/filings/0001628280-26-051898.md) | [86.8](/filings/0001628280-26-033633.md) | [87.2](/filings/0001628280-26-051898.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-015997.md) | not reported | not reported | not reported | [3.9](/filings/0001628280-26-051898.md) | [3.9](/filings/0001628280-26-033633.md) | [3.9](/filings/0001628280-26-051898.md) |
| Shareholders' equity | $m | [700](/filings/0000910638-24-000046.md) | [427](/filings/0001628280-26-015997.md) | [408](/filings/0001628280-25-048915.md) | [382](/filings/0001628280-25-048915.md) | [218](/filings/0001628280-25-048915.md) | [176](/filings/0001628280-26-051898.md) | [146](/filings/0001628280-26-051898.md) | [241](/filings/0001628280-26-051898.md) | [221](/filings/0001628280-25-048915.md) | [240](/filings/0001628280-26-051898.md) | [234](/filings/0001628280-26-051898.md) | [274](/filings/0001628280-26-051898.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(25.6) d](/filings/0000910638-24-000046.md) | [(8.8) d](/filings/0001628280-26-015997.md) | [(25.5)](/filings/0000910638-25-000010.md) | [(10.8) d](/filings/0000910638-25-000016.md) | [(0.8) d](/filings/0001628280-25-048915.md) | [(7.8) d](/filings/0001628280-26-015997.md) | [(33.8)](/filings/0001628280-26-033633.md) | [(25.8) d](/filings/0001628280-26-051898.md) | [(13.5) d](/filings/0001628280-25-048915.md) | [(14.7) d](/filings/0001628280-26-015997.md) | [(7.2)](/filings/0001628280-26-033633.md) | [(6.9) d](/filings/0001628280-26-051898.md) |
| Capital expenditure | $m | [7.4 d](/filings/0000910638-24-000046.md) | [6.2 d](/filings/0001628280-26-015997.md) | [3.2](/filings/0000910638-25-000010.md) | [4.0 d](/filings/0000910638-25-000016.md) | [3.6 d](/filings/0001628280-25-048915.md) | [5.3 d](/filings/0001628280-26-015997.md) | [2.8](/filings/0001628280-26-033633.md) | [2.9 d](/filings/0001628280-26-051898.md) | [2.3 d](/filings/0001628280-25-048915.md) | [1.9 d](/filings/0001628280-26-015997.md) | [2.1](/filings/0001628280-26-033633.md) | [3.8 d](/filings/0001628280-26-051898.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001628280-25-048915.md) | [0.0 d](/filings/0001628280-26-015997.md) | not reported | not reported | [0.0 d](/filings/0001628280-25-048915.md) | [0.0 d](/filings/0001628280-26-015997.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [128](/filings/0000910638-23-000025.md) | [129](/filings/0000910638-24-000035.md) | [130](/filings/0000910638-24-000041.md) | [130](/filings/0000910638-24-000046.md) | [131](/filings/0000910638-25-000010.md) | [132](/filings/0000910638-25-000016.md) | [132](/filings/0001628280-25-048915.md) | [132](/filings/0001628280-26-033633.md) | [183](/filings/0001628280-26-051898.md) | [125](/filings/0001628280-25-048915.md) | [143](/filings/0001628280-26-033633.md) | [149](/filings/0001628280-26-051898.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 166,147,027 at 2026-07-27, from the cover of the [10-Q filed 2026-08-03](/filings/0001628280-26-051898.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.